Pharmafile Logo

First Edition Translations Ltd

Founded in 1981, First Edition Translations Ltd is one of the UK’s oldest established translation agencies and a founder member of the Institute of Translation and Interpreting. Our team of professional medical translators are fluent in over 30 languages, ensuring your documents and materials are accurately translated.

First Edition offers diverse medical translation services that cover a broad range of materials, including:
Regulatory and legal documents
SPCs, PILs, labelling, treatment manuals
Clinical trials, assessments
Research studies, papers and abstracts
Information, manufacturing and marketing materials, IFUs
Specialist published materials, including catalogues, industry magazines and newsletters
Websites, apps and software

We value accuracy, reliability and outstanding quality, making us a trusted partner for all your medical and pharmaceutical translations. Adhering to the ISO 17100 standard, we can provide certification for our work upon request. If you’d like further advice, our friendly and multilingual project management team is always happy to help.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Atlas Translations Ltd

With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Company Details

6 Wellington Court, Wellington Street, Cambridge, CB1 1HZ, United Kingdom
+44 (0)1223 356 733

 Latest Content from PMHub 

Bigger than brand: Portfolio Positioning for Pharma

Senior Consultant Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

Tackling biosimilars – how to handle the threat to Pharma brands

Strategy Consultant Mark Assenti outlines three key points for developing a strategy to tackle the threat to Pharma brands from biosimilars.

Is Technology Harming Your Brain?

Is technology harming your brain? Saycomms healthcare PR team confronts different opinions on how technology affects memories and attention span.

Machine-made humans: a spooky prospect

The healthcare team at Saycomms PR asks if major advances in 3D printing and bioprinting could lead to machine-made humans.

Patient-Centricity: Improving the model with patient journeys

Head of Customer Experience Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient's journey at the centre.

Four Communications acquires Healthcare specialist MSA Media

Independent integrated communications agency, Four Communications Group has acquired 100 per cent of market-leading healthcare media planning & buying agency MSA Media.

The vitamin D deficiency: should we act?

Healthcare PR agency Say Communications analyses whether headlines are able to trigger a behavioural change with regards to the vitamin D deficiency issue.

Is obesity the new smoking?

Is obesity the new smoking? The healthcare PR team at Say communications analyses the question posed by NHS Chief executive Simon Stevens.

Children, the weight issue and how we deal with this responsibly?

Say Communication, Healthcare PR Agency, looks at how children deal with the weight issue and how we can approach it responsibly.